Max Robotics — Global Service Robot Directory + US Certification

About

Nathaniel Bouganim is an emerging clinical researcher whose work sits at the intersection of head and neck oncology and quality of life outcomes, with a particular focus on human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). His research centers on a pressing challenge in modern oncology: how to maintain excellent survival outcomes for HPV-related oropharyngeal cancer patients while meaningfully reducing the toxic burden of treatment. Bouganim has been instrumental in investigating neoadjuvant chemotherapy combined with transoral robotic surgery (TORS) as a promising deintensification strategy, addressing both distant metastasis — the leading cause of death in this population — and the debilitating short- and long-term side effects associated with conventional radiation-based therapy. His publications, accumulating over 25 citations since 2023, have appeared in high-impact venues including JAMA Otolaryngology–Head & Neck Surgery, signaling strong recognition within the field. Through descriptive and outcomes-based study designs, Bouganim has helped build the early evidence base for surgical-first approaches in HPV-OPSCC management, offering hope for patients seeking effective treatment with preserved function and quality of life.